Advertisement

Addressing Mental Health in Pediatric Rheumatology

  • Tamar B. RubinsteinEmail author
  • Alaina M. Davis
  • Martha Rodriguez
  • Andrea M. Knight
Pediatric Rheumatology (M Becker and J Harris, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Pediatric Rheumatology

Abstract

Purpose of review

To review the current evidence for the management of mental disorders for youth with rheumatologic diseases, and elucidate gaps in knowledge requiring further investigation to improve management of mental health conditions for these patients.

Recent findings

Depression and anxiety are common in youth with pediatric rheumatologic diseases and are associated with poor adherence, quality of life, and long-term outcomes. They have a complex etiology and require consideration of overall disease management as well as contributing psychosocial factors. Increasing evidence indicates that current screening strategies fail to fully support this patient population and that many patients with mental health problems go untreated.

Summary

Effective strategies to approach mental health in pediatric rheumatology patients are likely those that incorporate both behavioral and pharmacological therapies, and include families and social support. Preliminary evidence shows that adopting screening practices in pediatric rheumatology clinics will improve detection of mental disorders and is acceptable to patients and families. Broad mental health screening strategies should be considered for youth with rheumatologic diseases. Further research is necessary to better understand which treatments are most effective for depression, anxiety, and other forms of mental disorders observed in pediatric rheumatology.

Keywords

Pediatric rheumatology Mental health Depression Anxiety Screening Treatment Behavioral therapy 

Notes

Acknowledgements

The authors would like to thank the generous assistance of Aurelia Minuti, head reference librarian from Albert Einstein College of Medicine, for her guidance regarding searching algorithms used for this review.

Compliance with Ethical Standards

Conflict of Interest

Tamar Rubinstein declares that she has no conflict of interest.

Alaina Davis declares that she has no conflict of interest.

Martha Rodriguez declares that she has no conflict of interest.

Andrea Knight declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Bernstein CM, Stockwell MS, Gallagher MP, Rosenthal SL, Soren K. Mental health issues in adolescents and young adults with type 1 diabetes: prevalence and impact on glycemic control. Clin Pediatr (Phila). 2013;52(1):10–5.  https://doi.org/10.1177/0009922812459950.CrossRefGoogle Scholar
  2. 2.
    Bitsko MJ, Everhart RS, Rubin BK. The adolescent with asthma. Paediatr Respir Rev. 2014;15(2):146–53.  https://doi.org/10.1016/j.prrv.2013.07.003.PubMedGoogle Scholar
  3. 3.
    Calsbeek H, Rijken M, Bekkers MJ, Dekker J, van Berge Henegouwen GP. School and leisure activities in adolescents and young adults with chronic digestive disorders: impact of burden of disease. Int J Behav Med. 2006;13(2):121–30.  https://doi.org/10.1207/s15327558ijbm1302_3.PubMedCrossRefGoogle Scholar
  4. 4.
    Harrington R, Fudge H, Rutter M, Pickles A, Hill J. Adult outcomes of childhood and adolescent depression I. Psychiatric status. Arch Gen Psychiatry. 1990;47(5):465–73.PubMedCrossRefGoogle Scholar
  5. 5.
    Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne BJ, Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry. 2003;60(7):709–17.  https://doi.org/10.1001/archpsyc.60.7.709.PubMedCrossRefGoogle Scholar
  6. 6.
    Fombonne E, Wostear G, Cooper V, Harrington R, Rutter M. The Maudsley long-term follow-up of child and adolescent depression. 2. Suicidality, criminality and social dysfunction in adulthood. Br J Psychiatry J Ment Sci. 2001;179:218–23.CrossRefGoogle Scholar
  7. 7.
    Fergusson DM, Woodward LJ. Mental health, educational, and social role outcomes of adolescents with depression. Arch Gen Psychiatry. 2002;59(3):225–31.PubMedCrossRefGoogle Scholar
  8. 8.
    Currie J. Health disparities and gaps in school readiness. Future Child. 2005;15(1):117–38.PubMedCrossRefGoogle Scholar
  9. 9.
    Currie J, Stabile M. Child mental health and human capital accumulation: the case of ADHD. J Health Econ. 2006;25(6):1094–118.  https://doi.org/10.1016/j.jhealeco.2006.03.001.PubMedCrossRefGoogle Scholar
  10. 10.
    Knight A, Weiss P, Morales K, Gerdes M, Gutstein A, Vickery M, et al. Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study. Pediatric Rheumatol Online J. 2014;12:42.  https://doi.org/10.1186/1546-0096-12-42.CrossRefGoogle Scholar
  11. 11.
    • Krause ML, Zamora-Legoff JA, Crowson CS, Muskardin TW, Mason T, Matteson EL. Population-based study of outcomes of patients with juvenile idiopathic arthritis (JIA) compared to non-JIA subjects. Semin Arthritis Rheum. 2017;46(4):439–43.  https://doi.org/10.1016/j.semarthrit.2016.07.003. Analysis of medical records of age and sex-matched children with and without JIA showed that the incident depression in children with was higher than in controls.
  12. 12.
    Duzceker Y, Kanbur NO, Demirkaya E, Derman O, Moorthy LN, Ozen S. Quality of life measures and psychiatric symptoms in adolescents with systemic lupus erythematosus and familial Mediterranean fever. Int J Adolesc Med Health. 2014;26(4):541–9.  https://doi.org/10.1515/ijamh-2013-0332.PubMedCrossRefGoogle Scholar
  13. 13.
    Apaz MT, Saad-Magalhaes C, Pistorio A, Ravelli A, de Oliveira SJ, Marcantoni MB, et al. Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study. Arthritis Rheum. 2009;61(4):509–17.  https://doi.org/10.1002/art.24343.PubMedCrossRefGoogle Scholar
  14. 14.
    Sanner H, Gran JT, Sjaastad I, Flato B. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset. Rheumatology (Oxford). 2009;48(12):1541–7.  https://doi.org/10.1093/rheumatology/kep302.CrossRefGoogle Scholar
  15. 15.
    Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, et al. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum. 2004;51(3):458–64.  https://doi.org/10.1002/art.20412.PubMedCrossRefGoogle Scholar
  16. 16.
    Lim LS, Lefebvre A, Benseler S, Peralta M, Silverman ED. Psychiatric illness of systemic lupus erythematosus in childhood: spectrum of clinically important manifestations. J Rheumatol. 2013;40(4):506–12.  https://doi.org/10.3899/jrheum.120675.PubMedCrossRefGoogle Scholar
  17. 17.
    Knight A, Weiss P, Morales K, Gerdes M, Rearson M, Vickery M, et al. Identifying differences in risk factors for depression and anxiety in pediatric chronic disease: a matched cross-sectional study of youth with lupus/mixed connective tissue disease and their peers with diabetes. J Pediatr. 2015;167(6):1397–403.e1.  https://doi.org/10.1016/j.jpeds.2015.07.048.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    •• Knight AM, Trupin L, Katz P, Yelin E, Lawson EF. Depression risk in young adults with childhood- and adult-onset lupus: 12 years of follow-up. Arthritis Care Res (Hoboken). 2017;  https://doi.org/10.1002/acr.23290. Findings indicate that among young adult patients, those with childhood-onset SLE are more likely to have repeated depressive episodes than those with adult-onset.
  19. 19.
    Force USPST. Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force Recommendation Statement. Pediatrics. 2009;123(4):1223–8.  https://doi.org/10.1542/peds.2008-2381.CrossRefGoogle Scholar
  20. 20.
    Committee On P, Ambulatory M, Bright Futures Periodicity Schedule W. 2017 Recommendations for preventive pediatric health care. Pediatrics. 139(4).  https://doi.org/10.1542/peds.2017-0254.
  21. 21.
    Gortmaker SL, Walker DK, Weitzman M, Sobol AM. Chronic conditions, socioeconomic risks, and behavioral problems in children and adolescents. Pediatrics. 1990;85(3):267–76.PubMedGoogle Scholar
  22. 22.
    Newacheck PW, McManus MA, Fox HB. Prevalence and impact of chronic illness among adolescents. Am J Dis Child. 1991;145(12):1367–73.PubMedGoogle Scholar
  23. 23.
    Abou Abbas O, AlBuhairan F. Predictors of adolescents’ mental health problems in Saudi Arabia: findings from the Jeeluna(R) national study. Child Adolesc Psychiatry Ment Health. 2017;11:52.  https://doi.org/10.1186/s13034-017-0188-x.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Pinquart M, Shen Y. Depressive symptoms in children and adolescents with chronic physical illness: an updated meta-analysis. J Pediatr Psychol. 2011;36(4):375–84.  https://doi.org/10.1093/jpepsy/jsq104.PubMedCrossRefGoogle Scholar
  25. 25.
    Louthrenoo O, Krairojananan J, Chartapisak W, Opastirakul S. Psychosocial functioning of children with systemic lupus erythematosus. J Paediatr Child Health. 2012;48(12):1091–4.  https://doi.org/10.1111/j.1440-1754.2012.02499.x.PubMedCrossRefGoogle Scholar
  26. 26.
    Tarakci E, Yeldan I, Kaya Mutlu E, Baydogan SN, Kasapcopur O. The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol. 2011;30(11):1415–20.  https://doi.org/10.1007/s10067-011-1832-0.PubMedCrossRefGoogle Scholar
  27. 27.
    Noll RB, Kozlowski K, Gerhardt C, Vannatta K, Taylor J, Passo M. Social, emotional, and behavioral functioning of children with juvenile rheumatoid arthritis. Arthritis Rheum. 2000;43(6):1387–96. https://doi.org/10.1002/1529-0131(200006)43:6 < 1387::AID-ANR24 > 3.0.CO;2-C.Google Scholar
  28. 28.
    Postal M, Pelicari KO, Sinicato NA, Marini R, Costallat LT, Appenzeller S. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus. Cytokine. 2013;61(3):785–91.  https://doi.org/10.1016/j.cyto.2012.11.023.PubMedCrossRefGoogle Scholar
  29. 29.
    Ji L, Lili S, Jing W, Yanyan H, Min W, Juan X, et al. Appearance concern and depression in adolescent girls with systemic lupus erythematous. Clin Rheumatol. 2012;31(12):1671–5.  https://doi.org/10.1007/s10067-012-2071-8.PubMedCrossRefGoogle Scholar
  30. 30.
    Hoff AL, Palermo TM, Schluchter M, Zebracki K, Drotar D. Longitudinal relationships of depressive symptoms to pain intensity and functional disability among children with disease-related pain. J Pediatr Psychol. 2006;31(10):1046–56.  https://doi.org/10.1093/jpepsy/jsj076.PubMedCrossRefGoogle Scholar
  31. 31.
    Mullick MS, Nahar JS, Haq SA. Psychiatric morbidity, stressors, impact, and burden in juvenile idiopathic arthritis. J Health Popul Nutr. 2005;23(2):142–9.PubMedGoogle Scholar
  32. 32.
    • Jones JT, Cunningham N, Kashikar-Zuck S, Brunner HI. Pain, fatigue, and psychological impact on health-related quality of life in childhood-onset lupus. Arthritis Care Res (Hoboken). 2016;68(1):73–80.  https://doi.org/10.1002/acr.22650. Anxiety and depression correlate with overall health-related quality of life. Anxiety, along with pain, and fatigue impact health-related quality of life more than disease activity.
  33. 33.
    •• Knight AM, Xie M, Mandell DS. Disparities in psychiatric diagnosis and treatment for youth with systemic lupus erythematosus: analysis of a National US Medicaid Sample. J Rheumatol. 2016;43(7):1427–33.  https://doi.org/10.3899/jrheum.150967. The largest study to date of youth with SLE regarding mental health outcomes: 19% of Medicaid enrolled youth with lupus diagnosed with depression. Compared to white youth, African Americans are less likely to be diagnosed with depression or anxiety, or to be prescribed anxiolytics.
  34. 34.
    Yorgin P, Lazarow E, Sheets R. Patient health questionnaire-9 utilization for the detection of depression in adolescents and young adults with lupus nephritis. Arthritis Rheum. 2017;69.Google Scholar
  35. 35.
    Schanberg LE, Anthony KK, Gil KM, Maurin EC. Daily pain and symptoms in children with polyarticular arthritis. Arthritis Rheum. 2003;48(5):1390–7.  https://doi.org/10.1002/art.10986.PubMedCrossRefGoogle Scholar
  36. 36.
    Packham JC, Hall MA, Pimm TJ. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain. Rheum (Oxford, England). 2002;41(12):1444–9.CrossRefGoogle Scholar
  37. 37.
    Donnelly C, Cunningham N, Jones JT, Ji L, Brunner HI, Kashikar-Zuck S. Fatigue and depression predict reduced health-related quality of life in childhood-onset lupus. Lupus. 2017;961203317716317.  https://doi.org/10.1177/0961203317716317.
  38. 38.
    •• Knight AM, Vickery ME, Muscal E, Davis AM, Harris JG, Soybilgic A, et al. Identifying targets for improving mental healthcare of adolescents with systemic lupus erythematosus: perspectives from Pediatric Rheumatology Clinicians in the United States and Canada. J Rheumatol. 2016;43(6):1136–45.  https://doi.org/10.3899/jrheum.151228. Survey that described practice behaviors of pediatric rheumatologist regarding addressing mental health in patients, showing that few routinely screen for depression and anxiety, though the majority believe it is important.
  39. 39.
    Andermann A, Blancquaert I, Beauchamp S, Dery V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008;86(4):317–9.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Davis AM, Graham TB, Zhu Y, McPheeters ML. Cross-sectional analysis of depression and medication non-adherence in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2017;69:44–6.  https://doi.org/10.1002/art.v69.S4.Google Scholar
  41. 41.
    Knight AM, Davis AM, Klein-Gitelman MS, Cidav Z, Mandell D. The impact of psychiatric comorbidity on health care utilization for youth with systemic lupus erythematosus. Arthritis Rheum. 2017;69Google Scholar
  42. 42.
    Aasland A, Flato B, Vandvik IH. Psychosocial outcome in juvenile chronic arthritis: a nine-year follow-up. Clin Exp Rheum. 1997;15(5):561–8.Google Scholar
  43. 43.
    David J, Cooper C, Hickey L, Lloyd J, Dore C, McCullough C, et al. The functional and psychological outcomes of juvenile chronic arthritis in young adulthood. Br J Rheum. 1994;33(9):876–81.CrossRefGoogle Scholar
  44. 44.
    Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum. 2003;48(3):767–75.  https://doi.org/10.1002/art.10863.PubMedCrossRefGoogle Scholar
  45. 45.
    Tollisen A, Selvaag AM, Aulie HA, Lilleby V, Aasland A, Lerdal A et al. Physical functioning, pain and health-related quality of life in adults with juvenile idiopathic arthritis: a longitudinal 30-year follow-up study. Arthritis Care Res (Hoboken). 2017.  https://doi.org/10.1002/acr.23327.
  46. 46.
    Ramnath RAS, Groot N, Kaynak A, Bijl M, Dolhain RJEM, Teng YKO, et al. Adult outcomes in a large cohort of childhood-onset SLE patients: coping and resilience in relation to health-related quality of life-the CHILL-NL study. Pediatric Rheum. 2017;15:77.  https://doi.org/10.1186/s12969-017-0185-x.CrossRefGoogle Scholar
  47. 47.
    Tollisen A, Sanner H, Flato B, Wahl AK. Quality of life in adults with juvenile-onset dermatomyositis: a case-control study. Arthritis Care Res (Hoboken). 2012;64(7):1020–7.  https://doi.org/10.1002/acr.21637.Google Scholar
  48. 48.
    Arkela-Kautiainen M, Haapasaari J, Kautiainen H, Vilkkumaa I, Malkia E, Leirisalo-Repo M. Favourable social functioning and health related quality of life of patients with JIA in early adulthood. Ann Rheum Dis. 2005;64(6):875–80.  https://doi.org/10.1136/ard.2004.026591.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Peterson LS, Mason T, Nelson AM, O’Fallon WM, Gabriel SE. Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study. Arthritis Rheum. 1997;40(12):2235–40.  https://doi.org/10.1002/1529-0131(199712)40:12&lt;2235::AID-ART18&gt;3.0.CO;2-F.PubMedCrossRefGoogle Scholar
  50. 50.
    Yu HH, Lee JH, Wang LC, Yang YH, Chiang BL. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus. 2006;15(10):651–7.  https://doi.org/10.1177/0961203306070990.PubMedCrossRefGoogle Scholar
  51. 51.
    Steinlin MI, Blaser SI, Gilday DL, Eddy AA, Logan WJ, Laxer RM, et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol. 1995;13(3):191–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Beale IL. Scholarly literature review: efficacy of psychological interventions for pediatric chronic illnesses. J Pediatr Psychol. 2006;31(5):437–51.  https://doi.org/10.1093/jpepsy/jsj079.PubMedCrossRefGoogle Scholar
  53. 53.
    Wesselhoeft R, Sorensen MJ, Heiervang ER, Bilenberg N. Subthreshold depression in children and adolescents—a systematic review. J Affect Disord. 2013;151(1):7–22.  https://doi.org/10.1016/j.jad.2013.06.010.PubMedCrossRefGoogle Scholar
  54. 54.
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.PubMedCrossRefGoogle Scholar
  55. 55.
    Kovacs M. The Children’s Depression, Inventory (CDI). Psychopharmacol Bull. 1985;21(4):995–8.PubMedGoogle Scholar
  56. 56.
    Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 1999;38(10):1230–6.  https://doi.org/10.1097/00004583-199,910,000-00011.PubMedCrossRefGoogle Scholar
  57. 57.
    March JS, Parker JD, Sullivan K, Stallings P, Conners CK. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(4):554–65.  https://doi.org/10.1097/00004583-199,704,000-00019.PubMedCrossRefGoogle Scholar
  58. 58.
    Achenbach TM, Verhulst FC, Baron GD, Althaus M. A comparison of syndromes derived from the Child Behavior Checklist for American and Dutch boys aged 6–11 and 12–16. J Child Psychol Psychiatry. 1987;28(3):437–53.PubMedCrossRefGoogle Scholar
  59. 59.
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.  https://doi.org/10.1001/archinte.166.10.1092.PubMedCrossRefGoogle Scholar
  61. 61.
    Jellinek MS, Murphy JM, Robinson J, Feins A, Lamb S, Fenton T. Pediatric symptom checklist: screening school-age children for psychosocial dysfunction. J Pediatr. 1988;112(2):201–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Faulstich ME, Carey MP, Ruggiero L, Enyart P, Gresham F. Assessment of depression in childhood and adolescence: an evaluation of the Center for Epidemiological Studies Depression Scale for Children (CES-DC). Am J Psychiatr. 1986;143(8):1024–7.  https://doi.org/10.1176/ajp.143.8.1024.PubMedCrossRefGoogle Scholar
  63. 63.
    Brandon TG, Becker BD, Bevans KB, Weiss PF. Patient-reported outcomes measurement information system tools for collecting patient-reported outcomes in children with juvenile arthritis. Arthritis Care Res. 2017;69(3):393–402.  https://doi.org/10.1002/acr.22937.CrossRefGoogle Scholar
  64. 64.
    Choi SW, Schalet B, Cook KF, Cella D. Establishing a common metric for depressive symptoms: linking the BDI-II, CES-D, and PHQ-9 to PROMIS depression. Psychol Assess. 2014;26(2):513–27.  https://doi.org/10.1037/a0035768.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Kim J, Chung H, Askew RL, Park R, Jones SM, Cook KF, et al. Translating CESD-20 and PHQ-9 Scores to PROMIS Depression. Assessment. 2017;24(3):300–7.  https://doi.org/10.1177/1073191115607042.PubMedCrossRefGoogle Scholar
  66. 66.
    Julian LJ, Gregorich SE, Tonner C, Yazdany J, Trupin L, Criswell LA, et al. Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011;63(6):884–90.  https://doi.org/10.1002/acr.20447.CrossRefGoogle Scholar
  67. 67.
    Covic T, Pallant JF, Conaghan PG, Tennant A. A longitudinal evaluation of the Center for Epidemiologic Studies-Depression scale (CES-D) in a rheumatoid arthritis population using Rasch analysis. Health Qual Life Outcomes. 2007;5:41.  https://doi.org/10.1186/1477-7525-5-41.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Kohut SA, Williams TS, Jayanthikumar J, Landolt-Marticorena C, Lefebvre A, Silverman E, et al. Depressive symptoms are prevalent in childhood-onset systemic lupus erythematosus (cSLE). Lupus. 2013;22(7):712–20.  https://doi.org/10.1177/0961203313488840.PubMedCrossRefGoogle Scholar
  69. 69.
    Shaw KL, Southwood TR, McDonagh JE. Growing up and moving on in rheumatology: parents as proxies of adolescents with juvenile idiopathic arthritis. Arthritis Rheumatol. 2006;55(2):189–98.  https://doi.org/10.1002/art.21834.CrossRefGoogle Scholar
  70. 70.
    • Tunnicliffe DJ, Singh-Grewal D, Craig JC, Howell M, Tugwell P, Mackie F, et al. Healthcare and research priorities of adolescents and young adults with systemic lupus erythematosus: a mixed-methods study. J Rheumatol. 2017;44(4):444–51.  https://doi.org/10.3899/jrheum.160720. Quantitative and qualitative analysis of response from interviews of Australian youth with childhood-onset SLE, indicating that mental health is viewed as an area of high priority for both research and healthcare for youth with SLE.
  71. 71.
    Tennermann N, Hazen M. Patient and family reported psychosocial areas of concern within pediatric rheumatology: quality improvement data and implications for practice. Arthritis Rheum. 2017;69.Google Scholar
  72. 72.
    • Knight AM, Vickery ME, Fiks AG, Barg FK. Barriers and facilitators for mental healthcare in pediatric lupus and mixed connective tissue disease: a qualitative study of youth and parent perspectives. Pediatr Rheumatol Online J. 2015;13:52.  https://doi.org/10.1186/s12969-015-0049-1. Qualitative study that showed SLE/MCTD youth viewed pediatric rheumatologists as primary physicians and preferred screening and addressing mental health issues in the rheumatology setting.
  73. 73.
    Knight A, Vickery M, Fiks AG, Barg FK. The illness experience of youth with lupus/mixed connective tissue disease: a mixed methods analysis of patient and parent perspectives. Lupus. 2016;25(9):1028–39.  https://doi.org/10.1177/0961203316646460.PubMedCrossRefGoogle Scholar
  74. 74.
    Makay B, Emiroglu N, Unsal E. Depression and anxiety in children and adolescents with familial Mediterranean fever. Clin Rheumatol. 2010;29(4):375–9.  https://doi.org/10.1007/s10067-009-1330-9.PubMedCrossRefGoogle Scholar
  75. 75.
    Daltroy LH, Larson MG, Eaton HM, Partridge AJ, Pless IB, Rogers MP, et al. Psychosocial adjustment in juvenile arthritis. J Pediatr Psychol. 1992;17(3):277–89.PubMedCrossRefGoogle Scholar
  76. 76.
    Knight A, Vickery M, Muscal E, Davis A, Harris J, Hersh AO, et al. Mental health care for adolescents with rheumatologic conditions: perspectives from pediatric behavioral health providers in North America. Arthritis Rheumatol. 2016;68:3153–6.  https://doi.org/10.1002/art.39977.Google Scholar
  77. 77.
    Sibbitt WL Jr, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29(7):1536–42.PubMedGoogle Scholar
  78. 78.
    Reiss F. Socioeconomic inequalities and mental health problems in children and adolescents: a systematic review. Soc Sci Med. 2013;90:24–31.  https://doi.org/10.1016/j.socscimed.2013.04.026.PubMedCrossRefGoogle Scholar
  79. 79.
    Rubinstein T, Schwartz N, Jordan N, Lois R, Wahezi D, Stein REK, et al. Depression symptoms throughout the lifespan in a low-income, minority cohort of lupus patients: who is at risk? Arthritis Rheumatol. 2016;68:4331–3.  https://doi.org/10.1002/art.39977.Google Scholar
  80. 80.
    Son MB, Sergeyenko Y, Guan H, Costenbader KH. Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort. Lupus. 2016;25(13):1431–9.  https://doi.org/10.1177/0961203316640913.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Julian LJ, Tonner C, Yelin E, Yazdany J, Trupin L, Criswell LA, et al. Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011;63(4):542–9.  https://doi.org/10.1002/acr.20426.CrossRefGoogle Scholar
  82. 82.
    • Spiegel LR, Stinson J, Campillo S, Cellucci T, Dancey P, Duffy C, et al. An internet-based self-management program for adolescents with juvenile idiopathic arthritis (JIA): A randomized controlled trial (RCT). Pediatric Rheumatol. 2017;15:133.  https://doi.org/10.1186/s12969-017-0186-9. Large randomized control trial of an online behavioral intervention in JIA. Preliminary data does not show efficacy in improving outcomes regarding depression or anxiety.
  83. 83.
    Luca N, Daengsuwan T, Dalmau J, Jones K, deVeber G, Kobayashi J, et al. Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheumatol. 2011;63(8):2516–22.  https://doi.org/10.1002/art.30437.CrossRefGoogle Scholar
  84. 84.
    Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66(1):11–8.  https://doi.org/10.1002/ana.21756.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Ramanan AV, Sawhney S, Murray KJ. Central nervous system complications in two cases of juvenile onset dermatomyositis. Rheumatology (Oxford). 2001;40(11):1293–8.CrossRefGoogle Scholar
  86. 86.
    Deniz O, Caykoylu A, Vural G, Albayrak Y, Temel S, Aydin I, et al. A case study of neuro-psycho-Behcet’s syndrome presenting with psychotic attack. Clin Neurol Neurosurg. 2009;111(10):877–9.  https://doi.org/10.1016/j.clineuro.2009.07.009.PubMedCrossRefGoogle Scholar
  87. 87.
    Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin. 2010;28(1):61–73.  https://doi.org/10.1016/j.ncl.2009.09.004.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Parikh S, Swaiman KF, Kim Y. Neurologic characteristics of childhood lupus erythematosus. Pediatr Neurol. 1995;13(3):198–201.PubMedCrossRefGoogle Scholar
  89. 89.
    Muscal E, Nadeem T, Li X, Mian A, Harris TB. Evaluation and treatment of acute psychosis in children with systemic lupus erythematosus (SLE): consultation-liaison service experiences at a tertiary-care pediatric institution. Psychosomatics. 2010;51(6):508–14.  https://doi.org/10.1176/appi.psy.51.6.508.PubMedGoogle Scholar
  90. 90.
    ClinicalTrials.gov. National Library of Medicine, Bethesda, MD. Accessed 2017 Oct 30.Google Scholar
  91. 91.
    Soczynska JK, Kennedy SH, Goldstein BI, Lachowski A, Woldeyohannes HO, McIntyre RS. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Neurotoxicol. 2009;30(4):497–521.  https://doi.org/10.1016/j.neuro.2009.03.004.CrossRefGoogle Scholar
  92. 92.
    Gedik KC, Papaioannou H, Marcus M, Deutschman C, Gottlieb B. A prospective study to assess for changes in mood with initiation of anti-TNF therapy: a pilot study. Arthritis Rheumatol. 2017;69(Supp 4):82–5.Google Scholar
  93. 93.
    Hedayati SS, Gregg LP, Carmody T, Jain N, Toups M, Rush AJ, et al. Effect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence: the cast randomized clinical trial. JAMA. 2017;  https://doi.org/10.1001/jama.2017.17131.
  94. 94.
    • Lomholt JJ, Thastum M, Christensen AE, Leegaard A, Herlin T. Cognitive behavioral group intervention for pain and well-being in children with juvenile idiopathic arthritis: a study of feasibility and preliminary efficacy. Pediatr Rheumatol Online J. 2015;13:35.  https://doi.org/10.1186/s12969-015-0032-x. A pilot study of cognitive behavioral therapy for JIA patients and parents that showed a high rate of completion of therapy, but low participation rate among patients who eligible for the study.
  95. 95.
    Wagner JL, Chaney JM, Hommel KA, Page MC, Mullins LL, White MM, et al. The influence of parental distress on child depressive symptoms in juvenile rheumatic diseases: the moderating effect of illness intrusiveness. J Pediatr Psychol. 2003;28(7):453–62.PubMedCrossRefGoogle Scholar
  96. 96.
    Gomez-Ramirez O, Gibbon M, Berard R, Jurencak R, Green J, Tucker L, et al. A recurring rollercoaster ride: a qualitative study of the emotional experiences of parents of children with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14(1):13.  https://doi.org/10.1186/s12969-016-0073-9.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Walco GA, Varni JW, Ilowite NT. Cognitive-behavioral pain management in children with juvenile rheumatoid arthritis. Pediatrics. 1992;89(6 Pt 1):1075–9.PubMedGoogle Scholar
  98. 98.
    Degotardi PJ, Klass ES, Rosenberg BS, Fox DG, Gallelli KA, Gottlieb BS. Development and evaluation of a cognitive-behavioral intervention for juvenile fibromyalgia. J Pediatr Psychol. 2006;31(7):714–23.  https://doi.org/10.1093/jpepsy/jsj064.PubMedCrossRefGoogle Scholar
  99. 99.
    Warner J, Moorman E, Cunningham N, Wiley K, Watts A, Kashikar-Zuck S, et al. Development of cognitive behavioral therapy (CBT) for childhood-onset systemic lupus erythematosus (cSLE) treatment. Arthritis Rheumatol. 2017;69:144–5.  https://doi.org/10.1002/art.v69.S4.Google Scholar
  100. 100.
    Sansom-Daly UM, Peate M, Wakefield CE, Bryant RA, Cohn RJ. A systematic review of psychological interventions for adolescents and young adults living with chronic illness. Health Psychol. 2012;31(3):380–93.  https://doi.org/10.1037/a0025977.PubMedCrossRefGoogle Scholar
  101. 101.
    Zhou X, Hetrick SE, Cuijpers P, Qin B, Barth J, Whittington CJ, et al. Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: a systematic review and network meta-analysis. World Psychiatry. 2015;14(2):207–22.  https://doi.org/10.1002/wps.20217.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Sharpe L, Sensky T, Timberlake N, Ryan B, Allard S. Long-term efficacy of a cognitive behavioural treatment from a randomized controlled trial for patients recently diagnosed with rheumatoid arthritis. Rheumatol (Oxford). 2003;42(3):435–41.CrossRefGoogle Scholar
  103. 103.
    Navarrete-Navarrete N, Peralta-Ramirez MI, Sabio-Sanchez JM, Coin MA, Robles-Ortega H, Hidalgo-Tenorio C, et al. Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial. Psychother Psychosom. 2010;79(2):107–15.  https://doi.org/10.1159/000276370.PubMedCrossRefGoogle Scholar
  104. 104.
    von Weiss RT, Rapoff MA, Varni JW, Lindsley CB, Olson NY, Madson KL, et al. Daily hassles and social support as predictors of adjustment in children with pediatric rheumatic disease. J Pediatr Psychol. 2002;27(2):155–65.CrossRefGoogle Scholar
  105. 105.
    Timko C, Stovel KW, Moos RH. Functioning among mothers and fathers of children with juvenile rheumatic disease: a longitudinal study. J Pediatr Psychol. 1992;17(6):705–24.PubMedCrossRefGoogle Scholar
  106. 106.
    White MM, Chaney JM, Wagner JL, Andrews NR, Mullins LL, Hommel KA, et al. Children’s perceived illness uncertainty as a moderator in the parent-child distress relation in juvenile rheumatic diseases. Rehabil Psychol. 2005;50(3):224–31.  https://doi.org/10.1037/0090-5550.50.3.224.CrossRefGoogle Scholar
  107. 107.
    • Chaney JM, Gamwell KL, Baraldi AN, Ramsey RR, Cushing CC, Mullins AJ, et al. Parent perceptions of illness uncertainty and child depressive symptoms in juvenile rheumatic diseases: examining caregiver demand and parent distress as mediators. J Pediatr Psychol. 2016;41(9):941–51.  https://doi.org/10.1093/jpepsy/jsw004. Indicates that distress experienced by parents from perceptions about disease uncertainty can lead to depressive symptoms in patients with rheumatologic diseases in a moderately large, diverse group of patients.
  108. 108.
    Ireys HT, Sills EM, Kolodner KB, Walsh BB. A social support intervention for parents of children with juvenile rheumatoid arthritis: results of a randomized trial. J Pediatr Psychol. 1996;21(5):633–41.PubMedCrossRefGoogle Scholar
  109. 109.
    Haupt M, Millen S, Janner M, Falagan D, Fischer-Betz R, Schneider M. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis. 2005;64(11):1618–23.  https://doi.org/10.1136/ard.2004.029926.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Karlson EW, Liang MH, Eaton H, Huang J, Fitzgerald L, Rogers MP, et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum. 2004;50(6):1832–41.  https://doi.org/10.1002/art.20279.PubMedCrossRefGoogle Scholar
  111. 111.
    Stinson J, Ahola Kohut S, Forgeron P, Amaria K, Bell M, Kaufman M, et al. The iPeer2Peer Program: a pilot randomized controlled trial in adolescents with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14(1):48.  https://doi.org/10.1186/s12969-016-0108-2.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Shilling V, Morris C, Thompson-Coon J, Ukoumunne O, Rogers M, Logan S. Peer support for parents of children with chronic disabling conditions: a systematic review of quantitative and qualitative studies. Dev Med Child Neurol. 2013;55(7):602–9.  https://doi.org/10.1111/dmcn.12091.PubMedCrossRefGoogle Scholar
  113. 113.
    Williams EM, Egede L, Oates J, Voronca D, Gebregziabher M. Peer approaches to lupus self-management (pals): a novel lupus peer mentorship Intervention. Arthritis Rheumatol. 2016. 68 (suppl 10).Google Scholar
  114. 114.
    Williams EM, Egede L, Faith T, Oates J. Effective self-management Interventions for patients with lupus: potential impact of peer mentoring. Am J Med Sci. 2017;353(6):580–92.  https://doi.org/10.1016/j.amjms.2017.01.011.PubMedCrossRefGoogle Scholar
  115. 115.
    Cohen EM, Dossett ML, Mehta DH, Davis RB, Lee YC. Factors associated with complementary medicine use in pediatric musculoskeletal conditions: Results from a national survey. Complement Ther Med. 2017;31:53–8.  https://doi.org/10.1016/j.ctim.2017.02.001.PubMedCrossRefGoogle Scholar
  116. 116.
    Feldman DE, Duffy C, De Civita M, Malleson P, Philibert L, Gibbon M, et al. Factors associated with the use of complementary and alternative medicine in juvenile idiopathic arthritis. Arthritis Rheum. 2004;51(4):527–32.  https://doi.org/10.1002/art.20536.PubMedCrossRefGoogle Scholar
  117. 117.
    Field T, Hernandez-Reif M, Seligman S, Krasnegor J, Sunshine W, Rivas-Chacon R, et al. Juvenile rheumatoid arthritis: benefits from massage therapy. J Pediatr Psychol. 1997;22(5):607–17.PubMedCrossRefGoogle Scholar
  118. 118.
    Zebracki K, Holzman K, Bitter KJ, Feehan K, Miller ML. Brief report: use of complementary and alternative medicine and psychological functioning in Latino children with juvenile idiopathic arthritis or arthralgia. J Pediatr Psychol. 2007;32(8):1006–10.  https://doi.org/10.1093/jpepsy/jsm033.PubMedCrossRefGoogle Scholar
  119. 119.
    Ahola Kohut S, Stinson J, Davies-Chalmers C, Ruskin D, van Wyk M. Mindfulness-based interventions in clinical samples of adolescents with chronic illness: a systematic review. J Altern Complement Med. 2017;23(8):581–9.  https://doi.org/10.1089/acm.2016.0316.PubMedCrossRefGoogle Scholar
  120. 120.
    Carvalho MR, Sato EI, Tebexreni AS, Heidecher RT, Schenkman S, Neto TL. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;53(6):838–44.  https://doi.org/10.1002/art.21605.PubMedCrossRefGoogle Scholar
  121. 121.
    Zautra AJ, Davis MC, Reich JW, Nicassario P, Tennen H, Finan P, et al. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol. 2008;76(3):408–21.  https://doi.org/10.1037/0022-006X.76.3.408.PubMedCrossRefGoogle Scholar
  122. 122.
    Stinson JN, McGrath PJ, Hodnett ED, Feldman BM, Duffy CM, Huber AM, et al. An internet-based self-management program with telephone support for adolescents with arthritis: a pilot randomized controlled trial. J Rheumatol. 2010;37(9):1944–52.  https://doi.org/10.3899/jrheum.091327.PubMedCrossRefGoogle Scholar
  123. 123.
    Stinson J, Wilson R, Gill N, Yamada J, Holt J. A systematic review of internet-based self-management interventions for youth with health conditions. J Pediatr Psychol. 2009;34(5):495–510.  https://doi.org/10.1093/jpepsy/jsn115.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Tamar B. Rubinstein
    • 1
    • 2
    Email author
  • Alaina M. Davis
    • 3
  • Martha Rodriguez
    • 4
  • Andrea M. Knight
    • 5
    • 6
    • 7
  1. 1.Division of Pediatric RheumatologyChildren’s Hospital at MontefioreBronxUSA
  2. 2.Division of Pediatric RheumatologyAlbert Einstein College of MedicineBronxUSA
  3. 3.Monroe Carell Junior Children’s Hospital, Division of Pediatric RheumatologyVanderbilt University Medical CenterNashvilleUSA
  4. 4.Riley Hospital for Children at Indiana University Health, Section of Pediatric RheumatologyIndianapolisUSA
  5. 5.Division of RheumatologyThe Children’s Hospital of PhiladelphiaPhiladelphiaUSA
  6. 6.Center for Pediatric Clinical EffectivenessThe Children’s Hospital of PhiladelphiaPhiladelphiaUSA
  7. 7.Policy Lab, The Children’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations